Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106398 - 106398
Опубликована: Ноя. 1, 2024
Язык: Английский
Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106398 - 106398
Опубликована: Ноя. 1, 2024
Язык: Английский
Elsevier eBooks, Год журнала: 2024, Номер unknown, С. 373 - 397
Опубликована: Ноя. 29, 2024
Язык: Английский
Процитировано
5ChemistrySelect, Год журнала: 2025, Номер 10(16)
Опубликована: Апрель 1, 2025
Abstract Layered double hydroxides (LDHs) are emerging as versatile, nonviral vectors for gene delivery, offering significant potential in therapeutic applications. Their structure comprises positively charged metal hydroxide layers intercalated with anions, enabling efficient encapsulation of genetic materials like plasmids, small interfering RNA (siRNA), and messenger (mRNA). The anionic exchange capacity LDHs allows the controlled release nucleic acids, positioning them promising tools precision therapy. tunable composition enable optimization particle size, charge density, degradation rates to meet specific requirements. At cellular level, taken up via endocytosis, followed by intracellular trafficking, pH‐triggered material. This process protects acids from enzymatic ensures delivery cytoplasm or nucleus. They have successfully encapsulated siRNA effective silencing vitro vivo, downregulating disease‐associated genes conditions cystic fibrosis, muscular dystrophy, chronic viral infections. With their structural versatility, biocompatibility, acid poised revolutionize therapy personalized medicine, providing a safer alternative vectors. review highlights innovative carriers emphasizing structure, versatility targeted
Язык: Английский
Процитировано
0Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106398 - 106398
Опубликована: Ноя. 1, 2024
Язык: Английский
Процитировано
1